a2 Milk Co. (ASX:A2M, NZE:ATM) received approval from China's State Administration for Market Regulation to transfer two China-label infant milk formula registrations tied to its Pokeno facility to its a2 brand, according to a Monday filing with the New Zealand bourse.
The company confirmed that the acquisition of the a2 Pokeno facility is now irrevocable, given the receipt of all required regulatory approvals, per the filing.
The board is expected to meet soon to consider a NZ$300 million fully franked special dividend, with timing and details to be released upon formal approval, the filing added.